This week, Dexcom grew to become the primary medical machine firm to integrate generative AI right into a steady glucose monitor.
The corporate added generative AI to its Stelo glucose monitor, which it began selling 4 months in the past. The machine is an over-the-counter glucose biosensor that empowers people — each these with and with out diabetes — to actively monitor their metabolic well being.
Including generative AI to this glucose monitor will assist the machine higher analyze customers’ well being knowledge patterns, mentioned Dexcom COO Jake Leach.
The brand new AI platform analyzes knowledge from a wide range of sources — together with the Stelo biosensor, meal logging and different wearable applied sciences, he famous.
“One of many high items of suggestions we hear from customers is that they’re on the lookout for a extra customized expertise. What’s distinctive about our new [generative AI] platform that’s rolling out to Stelo customers is that they’ll have the option to higher contextualize the impression of what they eat, how they sleep, life-style habits and extra on their glucose ranges,” Leach defined.
He additionally identified that the AI platform enhances the present “weekly insights” characteristic throughout the Stelo app. Customers will now obtain extra customized suggestions about actions they’ll take to enhance their glucose management.
“As an illustration, when you expertise meal spikes after sure meals or occasions of day, you possibly can contemplate a fast stroll,” Leach acknowledged. “In fact, the insights can be tailor-made to every particular person and their private life-style selections. My ideas will look completely different than yours. In a means, Stelo will act as a pleasant well being ‘coach’ serving to shoppers make proactive, knowledgeable life-style choices.”
Stelo’s new generative AI capabilities are powered by Google Cloud’s AI fashions. Utilizing the tech big’s present AI fashions as a basis, Dexcom was in a position to construct its customized platform to collect and analyze knowledge from completely different sources, Leach defined.
Dexcom doesn’t share any consumer knowledge with Google, although, he famous.
“Tens of millions of individuals can profit from how our GenAI platform could make a long-term impression on their metabolic well being,” Leach acknowledged. “That is only the start. We imagine that AI will play a transformative position inside diabetes administration and healthcare by considerably offering a extra customized expertise, sharing extra actionable insights and thus enhancing well being outcomes for customers.”
Picture: metamorworks, Getty Photos